← Eichor
Condition: Autologous Hematopoietic Stem Cell Transplant Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Autologous Hematopoietic Stem Cell Transplant

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Study to Evaluate the Safety and Efficacy of Daratumumab and Carfilzomib-based Induction/Consolidation/Maintenance Thera
Phase 2 · 1 location(s) · Union Hospital, Tongji Medical College, Huazhong University · NCT06140966Pembrolizumab and Brentuximab Vedotin vs GDP and Stem Cell Transplant for Relapsed/Refractory Hodgkin Lymphoma
Phase 2 · 18 location(s) · Canadian Cancer Trials Group · NCT05180097Linperlisib-based Treatment Regimen in Newly Diagnosed Nodal T-follicular Helper Cell Lymphoma (nTFHL)
Phase 2 · 1 location(s) · Peking University · NCT06347653A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Dar
Phase 3 · 270 location(s) · Janssen Research & Development, LLC · NCT05552222Impact of Budesonide on Incidence of ≥ Gr2 Diarrhea in Multiple Myeloma (MM) Patients Undergoing Autologous Stem Cell Tr
Phase 2 · 1 location(s) · University of Utah · NCT05405387A Study Evaluating the Safety and Efficacy of LentiRed Drug Product in Transfusion-dependent β-Thalassemia [TDT]
EARLY_Phase 1 · 1 location(s) · First Affiliated Hospital of Guangxi Medical University · NCT05762510Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagn
Phase 3 · 117 location(s) · SWOG Cancer Research Network · NCT06022939Mobilization of Stem Cells With Motixafortide (BL-8040) in Combination With G-CSF in Multiple Myeloma Patients
Phase 3 · 2 location(s) · Guangzhou Gloria Biosciences Co., Ltd. · NCT06514508Immunological Reset to Enable Access to Hla-compatible Kidney Transplantation in Highly Sensitized Patients (RESET)
Phase 1/Phase 2 · 1 location(s) · Hospital Universitari Vall d'Hebron Research Institute · NCT07607197A Study Evaluating the Safety and Efficacy of the GMCN-508A Drug Product in Transfusion-dependent α-Thalassemia Particip
Phase 1 · 1 location(s) · First Affiliated Hospital of Guangxi Medical University · NCT05757245A Study of Melphalan With or Without Siltuximab in People With Multiple Myeloma Having an Autologous Stem Cell Transplan
Phase 2 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT06679829Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)
Phase 3 · 22 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT04047628AHSCT With Fludarabine and Cyclophosphamide Based Conditioning Regimes in Patients With Multiple Sclerosis
Phase 1 · 1 location(s) · St. Petersburg State Pavlov Medical University · NCT05832515PD-1 Inhibitors Maintenance for cHL Post-autoHCT
Phase 2 · 4 location(s) · St. Petersburg State Pavlov Medical University · NCT06812858Autologous Gene Therapy for Artemis-Deficient SCID
Phase 1/Phase 2 · 1 location(s) · University of California, San Francisco · NCT03538899Iberdomide vs. Iberdomide Plus Isatuximab Maintenance Therapy Post ASCT in Newly Diagnosed Multiple Myeloma
Phase 3 · 69 location(s) · University of Heidelberg Medical Center · NCT06216158Minimal Residual Disease Guided Maintenance Therapy With Belantamab Mafodotin and Lenalidomide After Autologous Hematopo
Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT05091372CNS-Relapse Prevention in High-Risk Diffuse Large B-cell Lymphoma With Thiotepa-based Autologous Stem Cell Transplant
Phase 2 · 1 location(s) · Washington University School of Medicine · NCT06687772Autologous Stem Cell Transplant Followed by Polatuzumab Vedotin in Patients With B-cell Non-Hodgkin and Hodgkin Lymphoma
Phase 1/Phase 2 · 1 location(s) · New York Medical College · NCT04491370Prehabilitation Exercise Training in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation
NA · 2 location(s) · Dana-Farber Cancer Institute · NCT05706766Mozobil for Autologous Hematopoietic Stem Cell Transplantation
Phase 2 · 1 location(s) · Thomas Jefferson University · NCT07188090A Phase 2 Study of Home Care Following Autologous Hematopoietic Stem Cell Transplantation
NA · 1 location(s) · Duke University · NCT03667599A Study of Brentuximab Vedotin in Adults With Hodgkin's Lymphoma
Phase N/A · 13 location(s) · Takeda · NCT05100056Elranatamab/Lenalidomide Consolidation and/or Elranatamab Maintenance Versus Standard of Care After D-VRd Induction in T
Phase 3 · 64 location(s) · Intergroupe Francophone du Myelome · NCT06918002High-Altitude Hematology Observation-Stem Cell Transplantation (HALO-SCT)
Phase N/A · 1 location(s) · Yigeng Cao,MD,PhD · NCT07205523PASCA-MM Study. Impact of the PASCA (PArcours de Santé au Cours du CAncer) Program on Complications Associated With Mult
NA · 6 location(s) · Centre Leon Berard · NCT05947136Orelabrutinib and Rituximab With Optional Autologous Hematopoietic Stem Cell Transplantation in MCL Treatment
Phase 2 · 1 location(s) · Ruijin Hospital · NCT07199296MT2022-60: Ph 2 Study of Pembro+ BEAM With ASCT for Relapsed Hodgkin Lymphoma
Phase 2 · 1 location(s) · Masonic Cancer Center, University of Minnesota · NCT06377540A Long-term Follow-up Study in Participants Who Received CS-101
NA · 1 location(s) · Children's Hospital of Fudan University · NCT06479616Helical Tomotherapy in Multiple Myeloma
NA · 1 location(s) · Fuling Zhou · NCT05970198
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.